We have recently identified a dominant wave of CD4-CD8-(double-negative [DN]) thymocytes in early murine fetal development that express low affinity Fc 3, receptors (FcyRII/III) and contain precursors for Tic~/3 lineage T cells. Here we show that Fc'yRII/III is expressed in very immature CD4 l~ single-positive (SP) thymocytes and that Fc3,RII/III expression is downregulated within the DN subpopulation and before the CD3-CD8 l~ SP stage in T call receptor (TCR)-a/3 lineage-committed thymocytes. DN Fc"t'RII/III + thymocytes also contain a small fraction of TCR-3'/t5 lineage cells in addition to TCR-c~/3 progenitors. Fetal day 15.5 DN TCR-a/B lineage progenitors can be subdivided into three major subpopulations as characterized by cell surface expression of Fc'yRII/III vs. CD2 (Fc'yRII/III+CD2 -, Fc3'RII/ III + CD2 +, Fc3,RII/III-CD2 +). Phenotypic analysis during fetal development as well as adoptive transfer of isolated fetal thymocyte subpopulations derived from C57B1/6 (Ly5.1) mice into normal, nonirradiated Ly5.2 congenic recipient mice identifies one early differentiation sequence (FcyRII/III + CD2-"-* Fc'yRII/III + CD2 + "-~ Fc3,RII/III-CD2 +) that precedes the entry of DN thymocytes into the CD4+CD8 + double-positive (DP) TCR l~ stage. Unseparated day 15.5 fetal thymocytes develop into DP thymocytes within 2.5 d and remain at the DP stage for >48 h before being selected into either CD4 + or CD8 + SP thymocytes. In contrast, Fc~/RII/ III+CD2 -DN thymocytes follow this same developmental pathway but are delayed by "~24 h before entering the DP compartment, while Fc'yRII/III-CD2 § display accelerated development by *24 h compared with total day 15.5 thymocytes. Fc'yRII/III-CD2 + are also more developmentally advanced than Fc3,RII/III+CD2 -fetal thymocytes with respect to their TCR ~/chain V(D)J rearrangement. At day 15.5 in gestation, ~ chain V(D)J rearrangement is mostly, if not entirely, restricted to the Fc3,RII/III-CD2 + subset of DN fetal thymocytes. Consistent with this analysis in fetal thymocytes, >90% of aduh thymocytes derived from mice carrying a disrupting mutation at the recombination-activating gene 2 locus (RAG-2-/-) on both alleles are developmentally arrested at the DN CD2-stage. In addition, there is a fivefold increase in the relative percentage of thymocytes expressing Fc3,RII/III in TCR and immunoglobulin gene rearrangementincompetent homozygous RAG-2-/-mice (15% Fc3,RII/III § versus rearrangement-competent heterozygous RAG-2 +/-mice (<3% FcyRII/III+). Thus, Fc3'RII/III expression defines an early DN stage preceding Vo(D~)Ja rearrangement, which in turn is followed by surface expression of CD2. Loss of Fc3,RII/III and acquisition of CD2 expression characterize a late DN stage immediately before the conversion into DP thymocytes.
Summary
We have recently identified a dominant wave of CD4-CD8-(double-negative [DN] ) thymocytes in early murine fetal development that express low affinity Fc 3, receptors (FcyRII/III) and contain precursors for Tic~/3 lineage T cells. Here we show that Fc'yRII/III is expressed in very immature CD4 l~ single-positive (SP) thymocytes and that Fc3,RII/III expression is downregulated within the DN subpopulation and before the CD3-CD8 l~ SP stage in T call receptor (TCR)-a/3 lineage-committed thymocytes. DN Fc"t'RII/III + thymocytes also contain a small fraction of TCR-3'/t5 lineage cells in addition to TCR-c~/3 progenitors. Fetal day 15.5 DN TCR-a/B lineage progenitors can be subdivided into three major subpopulations as characterized by cell surface expression of Fc'yRII/III vs. CD2 (Fc'yRII/III+CD2 -, Fc3'RII/ III + CD2 +, Fc3,RII/III-CD2 +). Phenotypic analysis during fetal development as well as adoptive transfer of isolated fetal thymocyte subpopulations derived from C57B1/6 (Ly5.1) mice into normal, nonirradiated Ly5.2 congenic recipient mice identifies one early differentiation sequence (FcyRII/III + CD2-"-* Fc'yRII/III + CD2 + "-~ Fc3,RII/III-CD2 +) that precedes the entry of DN thymocytes into the CD4+CD8 + double-positive (DP) TCR l~ stage. Unseparated day 15.5 fetal thymocytes develop into DP thymocytes within 2.5 d and remain at the DP stage for >48 h before being selected into either CD4 + or CD8 + SP thymocytes. In contrast, Fc~/RII/ III+CD2 -DN thymocytes follow this same developmental pathway but are delayed by "~24 h before entering the DP compartment, while Fc'yRII/III-CD2 § display accelerated development by *24 h compared with total day 15.5 thymocytes. Fc'yRII/III-CD2 + are also more developmentally advanced than Fc3,RII/III+CD2 -fetal thymocytes with respect to their TCR ~/chain V(D)J rearrangement. At day 15.5 in gestation, ~ chain V(D)J rearrangement is mostly, if not entirely, restricted to the Fc3,RII/III-CD2 + subset of DN fetal thymocytes. Consistent with this analysis in fetal thymocytes, >90% of aduh thymocytes derived from mice carrying a disrupting mutation at the recombination-activating gene 2 locus (RAG-2-/-) on both alleles are developmentally arrested at the DN CD2-stage. In addition, there is a fivefold increase in the relative percentage of thymocytes expressing Fc3,RII/III in TCR and immunoglobulin gene rearrangementincompetent homozygous RAG-2-/-mice (15% Fc3,RII/III § versus rearrangement-competent heterozygous RAG-2 +/-mice (<3% FcyRII/III+). Thus, Fc3'RII/III expression defines an early DN stage preceding Vo(D~)Ja rearrangement, which in turn is followed by surface expression of CD2. Loss of Fc3,RII/III and acquisition of CD2 expression characterize a late DN stage immediately before the conversion into DP thymocytes.
T lymphocytes develop in the thymus from fetal liver or adult bone marrow-derived progenitor cells that colonize the fetal thymus continuously beginning around day 12 in the development of the mouse (1, 2) . Progenitor activity giving rise to both T cell (Tiot//~ and Ti3'//$) lineages has been identified in the CD4-CDS-double-negative (DN) 1 population of thymocytes (reviewed in references [3] [4] [5] [6] . DN thymocytes represent the major population in the early fetal thymus ('~95% at day 15.5 in gestation of the mouse) and are reduced to ~5% in the adult thymus due to the presence of more developed thymocytes. TCK-od~ lineage thymocytes begin to rearrange their TCK genes at the DN stage (7) (8) (9) and pass through a CD3-CD8 I~ (10, 11) stage into the CD4 + CD8 + double-positive (DP) TCR l~ stage. On the basis of their TCK specificity, DP thymocytes are selected into CD4 + or CDS+TCR.hig a single-positive (SP) mature thymocytes that populate the peripheral lymphoid organs (reviewed in reference 12).
We have recently identified a wave of DN thymocytes in early fetal development (day 14.5 in gestation) that express Fc receptors for IgG (FcyKII/III) (13) . Intrathymic transfer of purified fetal DN Fc'yKII/III + thymocytes demonstrated the Tio~/~ lineage progenitor activity of these cells. Developmental progression included the conversion from the CD3-CD4-CD8-FcTKII/III § stage to the CD3+CD4+CD8+ stage and the subsequent selection into CD4 or CD8 SP mature T cells. Of note, FcyKII/III expression was shown to be downregulated between the DN and DP stages. However, CD3 -CD4-CD8-Fc~RII/III § thymocytes also contained precursor activity for the generation of NK cells. This property became apparent upon removal of fetal thymocytes from the thymus and subsequent in vitro culture in the presence of IL-2 or upon intravenous transfer into recipient mice. In contrast to the loss of FcTKII/III expression during intrathymic development, FcTRII/III expression was maintained on cellular progeny derived from CD3-CD4-CD8 -Fc'yRII/ III + cells outside the thymus (13) .
While the percentage of FcyKII/III-expressing thymocytes declines during early fetal development, the number of CD2-expressing thymocytes increases (14, 15) . The early onset of CD2 expression (day 14 in gestation) in developing thymocytes led to the speculation that CD2-mediated adhesion and/or signaling might play a role in thymus-specific differentiation (16) . Furthermore, the loss of Fc'yKII/III expression and the acquisition of CD2 expression during early T cell ontogeny suggest that there are additional developmentally and phenotypically distinct subpopulations of DN thymocytes just before the transition into the DP stage. Here we report on the identification of such distinct subsets of DN thymocytes as defined by their expression of Fc'yKII/III and CD2, their TCR/3 chain rearrangement status, and their in vivo differentiation kinetics in normal recipient mice. The elucidation of this developmental sequence within DN thymocytes is entirely consistent with the differentiation block that 1 Abbreviations used in this paper: DN, double negative; DE double positive; HSA, heat-stable antigen; KAG-2, recombination-activating gene 2; SP, single positive. occurs in TCR gene rearrangement-incompetent animals whose RAG-2 genes (17, 18) have been disrupted on both alleles (19) . Moreover, analysis of CD3-CD4-CD8-thymocytes from adult mice identified the same phenotypic stages as found among fetal thymocytes, suggesting that these subpopulations of DN thymocytes are part of a functional developmental pathway in the adult thymus as well. Finally, while the majority of the DN FcyRII/III + subset are apparently TCR-ol//~ progenitors, a small fraction of DN FcyRII/III + thymocytes enter the TCR-y/8 lineage.
Materials and Methods
Mice. C57B1/6 (Ly5.1) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and breeding stocks of the congenic strain B6Ly5.2 (Ly5.2) were kindly provided by Dr. Clarence Reeder (National Cancer Institute, Frederick, MD) and maintained at the Redstone Animal Facility at the Dana-Farber Cancer Institute (Boston, MA). Thymocytes were isolated from fetal mice that were obtained from timed pregnant C57B1/6 mice. The day of the vaginal plug was counted as day 1 of pregnancy. RAG-2 -/-and RAG-2 +/-mice (19) were kept under specific pathogen-flee conditions.
mAbs. The following primary antibodies were used in this study: biotinylated 2.4G2, FITC-conjugated 2.4G2 (20) , PE-coupled 53-2.1 (21) (anti-Thy-1; Gibco BRL, Gaithersburg, MD), FITCconjugated M1/69 (22) (anti-HSA; Pharmingen, San Francisco, CA), biotinylated 7D4 (23) (antiqL-2R [p55]), biotinylated RM2-1 (24) (anti-CD2; Pharmingen), control antibody Y13-238 (25) (antip21 ras), PE-coupled YCD3-1 (26) (anti-CD3; Gibco BRL), FITClabeled 145-2Cll (anti-CD3) (27) , FITC-labeled 3A10 (anti-pan Ti'y/~) (28) PE-coupled GK1.5 (29) (anti-CD4; Becton Dickinson & Co., Mountain View, CA), biotinylated 53-6.7 (21) (anti-CD8; Becton Dickinson & Co.), Ked613-coupled 53-6.7 (anti-CD8; Gibco BRL), PE-coupled RA3-6B2 (30) (anti-B220; Caltag, San Francisco, CA), aUele-specific FITC-conjugated 104-2.1 (anti-Ly5.1) (31), FITC-labeled A20-1.7 (anti-LyS.2) (31). Both hybridomas were kindly provided by Dr. S. Kimura (Sloan-Kettering Cancer Center, New York). Second-step reagents were streptavidin-PE and streptavidin-FITC (Tago Inc., Burlingame, CA). mAbs were grown as culture supernatants and depending on the species and isotype purified on protein A-or protein G-Sepharose (Pharmacia LKB, Uppsala, Sweden). mAbs were biotinylated using NHS-LC-Biotin (Pierce Chemical Co., Rockford, IL) following the manufacturer's recommendations and FITC labeled using fluorescein-5-isothiocyanate (FITC Isomer I; Molecular Probes, Eugene, OR) using standard procedures (32) . Following the labeling procedures, specific reactivity of mAbs was analyzed by FACS | (Becton Dickinson & Co.) and the optimal antibody dilutions were subsequently used.
Immunofluorescence Staining Analysis, and Cell Sorting. For phenotypic analysis, thymocytes were obtained from normal fetal mice at different days of timed pregnancies, or at the indicated times after cell transfer into recipient mice, and stained with mAbs as indicated in the figure legends. 0.5-1 x 106 cells from single-cell suspensions were incubated with purified mAbs at 5-10/~g/ml in PBS, 5% FCS for 15-30 min on ice, washed in PBS, 5% FCS and, if necessary, incubated with the appropriate second-step reagents for 15-30 min on ice. Flow cytofluorometric analysis was performed on a FACScan | (Becton Dickinson & Co.). In experiments shown in Figs. 1-3, 6 , and 7, 104 cells were analyzed. For reanalysis of donor-type cells (summarized in Fig. 4 B) , 5 x 104 cells were analyzed, in each case gating on viable cells by forward angle and sideward scattering properties. Fluorescence data are displayed as loga-rithmic overlay histograms, contour, or dot plots using LYSYS software (Becton Dickinson & Co.).
For cell sorting, fetal thymocytes derived from timed pregnant C57B1/6 mice (day 15.5) were stained with 2.4G2-FITC (10/zg/ml) and CD2-biotin (1:50 dilution) followed by avidin-PE (1:50 dilution) and separated into CD2 § Fc3,RII/III-and CD2-Fcq, RII/ III + subpopulations at a flow rate of 1,500 cells/s using an EPICS 750 series cell sorter (Coulter Electronics, Hialeah, FL). Sorted cell populations were reanalyzed for their purity and were found to be at least 97% pure. For control purposes, fetal day 15.5 thymocyte (FT day 15.5) total cells were stained with 2.4G2-FITC (10 #g/ml) and CD2-biotin (1:50 dilution), followed by avidin-PE, but not separated before intrathymic injection.
Enrichment of Ly5.1 + Cells through Magnetic Bead Separation. For enrichment of LyS.1 § cells from Ly5.2 recipient mice, thymocytes were incubated with purified A20-1.7 (anti-LyS.2) at 10 #g/ml for 30 rain on ice and washed in PBS, 5% FCS. Magnetic goat anti-mouse IgG beads (Advanced Magnetics, Cambridge, MA) were washed twice by placing the magnetic bead suspension between two strong magnets, removing liquid, and resuspending beads in PBS, 5% FCS. Thymocytes were then incubated with magnetic beads (1 ml magnetic bead suspension/107 cells) for 30 min on ice. To remove LyS.2 § cells bound to magnetic beads, the suspension was placed between two magnets until fluid was clear (,o5 min). Fluid, enriched in Ly5.1 + cells, was then removed and again incubated with an equivalent amount of magnetic beads for 30 min on ice. For the final separation, the suspension was placed between magnets and the transparent fluid removed. This last step was repeated three times to obtain maximum enrichment of LyS.1 § cells. This procedure yielded 5-50-fold enrichment of donor-type cells relative to host cells. In general, 50-500 (0.1-1%) donor-type cells were observed per 5 x 104 total thymocytes analyzed with no significant difference detected when comparing the cell numbers of progeny of the injected DN FcyRII/III+CD2 -and DN FcyRII/III-CD2 + subpopulations.
Isolation of Adult CD3-CD4-CD8-Thymocytes. To prepare adult CD3-CD4-CDS-thymocytes, normal adult thymocytes were incubated at a concentration of 2 x 10Vml with PE-coupled GK1.5 (10 #g/ml) and biotinylated 53-6.7 (10 #g/ml) for 30 min on ice. After extensive washing the cells were resuspended at a concentration of 107/ml with magnetic goat anti-rat IgG beads (Advanced Magnetics) at a ratio of 10-50 particles/cell and incubated for 30 min on ice. CD4 + and CD8 + thymocytes binding to magnetic beads were subtracted using two magnets (Advanced Magnetics) as described above. The latter step was repeated twice. By this time, CD4-and CD8-thymocytes were enriched to "o60%. To further purify the DN population and to remove DN CD3 + cells, the remaining cell population was restained with PE-coupled GK1.5 (10 #g/ml), biotinylated 53-6.7 (10 #g/ml), and PE-coupled YCD3-1 for 30 min on ice, washed, and subsequently incubated with streptavidin-PE. PE-negative thymocytes (corresponding to CD3-CD4-CDS-thymocytes) were sorted on an EPICS 750 series cell sorter (Coulter Electronics). Postsorter analysis showed the purity of the sorted population to be >97%.
Intrathymic Injections. Intrathymic injections were performed as described (13, 33, 34) . Briefly, 4-6-wk-old mice were anesthetized with Avertin (2.5% solution, 10/A per gram body weight) as described (35) and injected intrathymically without prior irradiation. For injections, mice were positioned on their back, a small incision (<5 mm) was made in the skin above the sternum without opening the thorax, and cells were injected into each thymic lobe by positioning the needle for injection from cranio-lateral to caudo-medial and injecting through the thorax wall above the clavicle. Cells (10S/thymus) were injected using a 1-ml syringe (Insulin Syringe; Becton Dickinson & Co., Rutherford, NJ) placed into a stepper (Tridak, Brookfield, CT) in 20 #1 PBS with 5% FCS per lobe. Subsequently, the skin wound was closed using surgical metal clips.
Template Preparation for PCR Analysis. Genomic DNA from various tissues was isolated from C57B1/6 mice. Single-cell suspensions from fetal liver, fetal thymus, and adult lymph nodes were washed in cold PBS, resuspended in cold PBS, 0.5% NP-40, and incubated on ice for 15 min. Nuclei were spun down, resuspended in 0.5 ml TNE (50 mM Tris, 100 mM NaC1, 1 mM EDTA) with 0.5 mg/ml proteinase K and 1% SDS, and incubated overnight at 37~ Genomic DNA was extracted once with TE-saturated phenol and once with chloroform and precipitated with 0.3 M NaOAc (pH 5.9) and ethanol.
PCR and Southern Hybridization Analysis. PCR was carried out as described (36) . In brief, we used "o100 ng (or dilutions thereof) of DNA template, 5 pmol of primers Jf12.5 (5'-TAACACGAC-GAGCCGAGTGC-3') and Vfl6 (5'-GAAGGCTATGATGCGTC-TCG-Y), 10 pmol of primer Vfl8 (5'-TCCCTGATGGGTACAA-GGCC-Y), and 1 U of taq polymerase (Perkin Elmer Cetus, Norwalk, CT) in 50 #1 final volume. The samples were denatured (94~ 1 min), annealed (64~ 1 min) and extended (72~ 30 s) for 35 cycles. Aliquots from each sample were size fractionated on a 1.5% Tris-borate-EDTA agarose gel, denatured in 0.25 M HC1, and blotted onto a zeta probe membrane (Bio-Rad Laboratories, Richmond, CA) in 0.4 M NaOH. Blots were then hybridized with a Jfl2.5-specific oligonucleotide probe (5'-CTGGCCCAAAGTACT GGGTG-Y) using standard methods (36) .
To control the integrity and amount of genomic DNA templates, a genomic sequence within exon 8 of CD3~" was amplified using the sense oligonucleotide (5'-CAGACCCTGGCC CCTCGC-3') and the antisense oligonucleotide (5'-GCTACCCCAGGCT-CACCAC-Y). The samples were denatured (94~ 1 min), annealed (62~ 1 rain), and extended (72~ 1.5 rain) for 35 cycles. Blots were hybridized with a CD3~" exon 8-specific oligonucleotide probe (5'-GGGCTTCACCTGCTGATGTC-3'). All oligonucleotides were made on a synthesizer (381A; Applied Biosystems, Inc., Foster City, CA) using standard fl-cyanoethylphosphoramidate chemistry.
Statistical Analysis. To determine the statistical significance of kinetic differences in the development of various fetal thymocyte populations 1.5-7.5 d postintrathymic injection as measured in the experiments summarized in Fig. 4 B, a permutation test (37) was used to determine the difference between the control population (FT day 15.5 total) and either Fc3,RII/III+CD2 -or Fcq, RII/ III-CD2 § . The test statistic used was the sum, over times, of the squares of the differences between the sample averages of the percentages. The permutations were the relabelings of group identity that fixed the number of observations at each time and in each group (with p <0.001). subsets. Gated subpopulations of DN, CD8 l~ SP, and DP ( Fig. 1 A) were analyzed for their expression levels of FcTRII/III. This analysis revealed the highest expression of FcTKII/III on the DN population, while both immature CD8 l~ SP and DP thymocytes are FcTRII/III-( Fig. 1 B) . Overlay histograms shown in Fig. 1 B compare specific staining of thymic subpopulations with FITC-labeled mAb 2.4G2 (bold lines) vs. 2.4G2-FITC staining of the same subpopulations after preincubation with an excess of unlabeled 2.4G2 (thin lines). This expression pattern is consistent with our previous observation of a parallel decline in the percentage of DN and FcTRII/III + fetal thymocytes during gestation in situ as well as the loss of Fc3,RII/III on adoptively transferred FcTRII/III + DN T cell progenitors during their development from the DN to the DP stage in the thymus (13) .
Results

Expression of Fo, RII/III on Fetal
The above results indicated that FcTRII/III expression is found at the DN stage and lost before further differentiation. To analyze FcyRII/III expression on yet earlier intrathymic progenitor cells, we examined the 2.4G2 reactivity on the recently described CD4 ~~ SP immature population, which precedes the DN stage (38, 39) . Three-color immunofluorescence analysis on FT day 15.5 for CD4, CDS, and FcTRII/III ( Fig. 1 C) revealed that FcTRII/III was also expressed on the majority of the CD4 l~ SP immature population ( Fig. 1 D) . This finding indicates that a very early intrathymic T cell progenitor population expresses Fc3,KII/III.
Several Distinct Subpopulations of DN Fetal Thymocytes Are Defined during Early Development by FcyRII/III Expression.
DN thymocytes can be subdivided into phenotypic subpopulations by expression of a number ofceU surface proteins (40, 41) , i.e., the IL-2R eL chain (p55) (34, 42) , the levels of expression of Thy-1 (43), heat-stable antigen (HSA) (44, 45) , and CD2 (14, 15) . To analyze the presence or absence of these early stage-related markers on FcTKII/III § and FcTKII/ III-thymocyte populations, thymocytes derived from days 14.5, 15.5, and 16.5 of fetal development, respectively, were stained for expression of Fc'yKII/III vs. Thy-1 ( Fig. 2 A) , IL-2R (p55) (Fig. 2 B) , CD2 (Fig. 2 C) , and HSA (Fig. 2  D) . This analysis reveals heterogeneity among FcTRII/ III + and FcTKII/III-thymocytes. While the majority of FcTKII/III + thymocytes at day 14.5 are Thy-lhig h and HSAhig h (Fig. 2, A and D, top) , a minority of Fc3,RII/III + thymocytes express medium to low levels of Thy-1 and HSA. As has been described previously, the number of FcyRII/III + thymocytes drastically declines during fetal development (13) . However, the expression levels of Thy-1 and HSA remain high during the Ec3,RII/III downregulation (Fig.  2, A and D) . In contrast, analysis of developing thymocytes for FeyRII/III vs. Ib2R (p55) (Fig. 2 B) reveals a major population of predominantly FcyRII/III + IL-2R (p55) + day 14.5 thymocytes and a minor population of FcyRII/III + IL-2R (p55) ~~ day 14.5 thymocytes (Fig. 2 B, top) . The loss of Fc3,RII/III appears to precede the loss of IL-2R (p55) on day 15.5 fetal cells (Fig. 2 B, middle) , before thymocytes enter a Fc~/RI[/III-IL-2R (p55)-stage on day 16.5 ( Fig. 2 B, bottom). Analysis of cell surface expression of Fcq'RII/III vs.
CD2 (Fig. 2 C) demonstrates that the majority of Fc3,RII/III + thymocytes at day 14.5 are CD2 l~ (Fig. 2 C, top). As thymic development proceeds, thymocytes appear to first enter a Fcq, RII/III + CD2 + stage (Fig. 2 C, middle) , be- (28), fetal thymocytes from this day of gestation were analyzed by flow cytometry for coexpression of FcyRII/III and CD3 (Fig. 3 C) or TCR-7/~ (Fig. 3 D) , respectively. Negative and single-color controls are shown in Fig. 3, A and B . Specificity of the anti-CD3 and antiTClk-3,/t~ staining was ensured by control cells that were preincubated with an excess of unlabeled mAb 2Cll (anti-CD3) or unlabeled mAb 3A10 (anti-pan TCR-3'/6) before staining with 2ClI-FITC (Fig. 3, A and B) or 3AIO-FITC (not shown). Confirming the dominance of TCR-3'/~ cells among early TCR thymocytes (28, 46) , this analysis revealed '~5% CD3 § cells at day 16.5 of gestation (Fig. 3 C) that belong almost entirely to the TCR-y//~ lineage (Fig. 3 D) . The vast majority of Fcq, RII/III + thymocytes are CD3-, which is consistent with the observed downregulation of Fcq, RII/III at the DN stage (Fig. 1, A and B) . However, a small fraction of DN Fc3,RII/III + thymocytes also coexpress CD3 (Fig.  3 C) and are TCR-3,/~ lineage cells (Fig. 3 D Fig. 4 A (left) . Day 15.5 of gestation represents a stage of development containing FcyRII/III + CD2-, Fc3,RII/III + CD2 +, and FcyRII/III-CD2 + subpopulations (Fig. 2 C, middle, and Fig. 4 A) . Postsorter analysis showed that the isolated Fc3,RII/III + CD2-thymocytes contained x<0.5% of contaminating cells from the Fc3,RII/III-CD2 + subpopulation. The Fc3,RII/ III-CD2 + subset of DN thymocytes gated by cell sorter was -.<3% contaminated by Fc3'RII/III+CD2 -thymocytes. Subsequently, the developmental stage and differentiation potential of these early thymocyte subpopulations were assessed. To this end, the in vivo development of total DN day 15.5 thymocytes was compared in parallel to putatively more immature Fc3,RII/III+CD2 -and more mature FcTRII/III-CD2 + subpopulations, respectively, by intrathymic injection of individual subpopulations.
Since preliminary experiments revealed a general developmental delay of ,04 d when FT day 15.5 were transferred into irradiated recipients when compared with nonirradiated recipients (data not shown), all subsequent experiments for in vivo precursor activity and kinetics were performed in nonirradiated recipients. Precursor cell transfer into the nonirradiated thymic microenvironment should facilitate donor cell development that closely resembles the development in the normal thymus and allows "real-time" measurements between developmental steps in vivo (34) . Consequently, cell sorterpurified thymocyte subpopulations from C57B1/6 mice (LyS.1) were injected intrathymically (10 s cells/thymus) into normal, nonirradiated B6Ly5.2 congenic mice. In daily intervals from 1.5 to 7.5 d after cell transfer in vivo, donor-type thymocytes were retrieved from recipient thymi. Donor-type thymocytes were enriched relative to host thymocytes by depletion with anti-Ly5.2 mAb and goat anti-mouse magnetic beads followed by magnetic separation. Subsequently, developmental progression of donor-type thymocytes was analyzed by threecolor immunofluorescence for Ly5.1, CD4, and CDS.
All three tested populations from day 15.5 in gestation (FT day 15.5 total, Fc3,RII/III+CD2 -, and Fcq, RII/III-CD2 +) give rise to an initial single wave of DP (Fig. 4 B, top) and subsequently mature SP thymocytes (Fig. 4 B, bottom) , indicating their T cell progenitor activity in a thymic environment. 2.5 d after intrathymic injection of total FT day 15.5, ,090% of donor-type cells are at the DP stage. Beginning at day 4.5 postinjection (duration of the DP stage >--48 h), the number of DP declines as donor-type thymocytes are selected into CD4 SP (Fig. 4 B) and CD8 SP (not shown) mature cells. By day 7.5 postinjection, <10% of donor-type thymocytes are DP. At this time and later (day 10.5; Fig.  4 B, bottom) , cellular progeny of total day 15.5 fetal progenitors have generated ,060% CD4 SP and "~30% CD8 SP (not shown) thymocytes, thus reflecting the proportions of CD4 + (Fig. 4 B, bottom right) to CD8 + mature donor-type T cells found in the periphery.
A shift in the kinetics of individual subpopulations was detected when this in vivo differentiation analysis in normal mice was applied in parallel experiments to DN subpopulations characterized by selective expression of FcyRII/III and CD2. Both precursor cell populations give rise to a single wave of DP thymocytes. However, DN FcTRII/III + CD2-displayed delayed developmental kinetics by ,024 h when compared with total FT day 15.5, while DN FeyRII/III-CD2 + showed accelerated development by ,024 h. To test the statistical significance of the observed kinetic differences, a permutation test was used to analyze the difference between the control population (FT day 15.5 total) and either Fc3,RII/ III+CD2 -(p <0.001) or Fc3,RII/III-CD2 + (p <0.001). While ,070% of the cellular progeny of DN Fcq, RII/III-CD2 + were at the DP stage after 1.5 d in vivo, only "015% of Ly5.1 donor-type cells had developed into DP thymocytes at this time point after injection of DN FcyRII/III + CD2- (Fig. 4 B) . Consequently, the first mature SP cells (CD4 SP) began to appear 3.5 d after transfer of DN FcyRII/III-CD2 +, in contrast to 5.5 d for DN FcyRII/III+CD2 -. Note that the decline of the percent of DP donor-type thymocytes corresponds to the transition from the DP to the SP stage as shown in Fig. 4 B. Collectively, these experiments demonstrate that the Fe~RII/III + CD2-subpopulation represents an early DN stage while FcTRII/III-CD2 + mark a late stage among DN fetal thymocytes. The developmental lag time between the two analyzed populations is "48 h.
TCR fl'Chain V(D)J Rearrangement Status in FT Day 15.5 Subpopulations.
The first molecular hallmark of immature thymocytes entering the Tict/B lineage is V(D)J rearrangement of the TCR/5 chain locus followed by VJ rearrangement of the oe chain locus (reviewed in reference 9). Thus, V(D)J rearrangement of the TCR B chain locus was analyzed in Fc'yRII/III+CD2 -and FcyRII/III-CD2 + subpopulations of DN thymocytes derived from day 15.5 of gestation. A sensitive PCR-based analysis for TCR gene rearrangement (36) was used as outlined in Fig. 5 A. The PCR amplification was carried out utilizing two sense primers hybridizing to two VB genes, VB6 and Vfl8, respectively, and one antisense primer recognizing one J~/element, JB2.5. Two different V/3-specific primers were used to increase the percentage of cells that are included in the analysis for V(D)J rearrangement of the TCR B chain. Since the somatic recombination process leads to joining of a D to a J element and subsequently joining of V to DJ, the DNA sequences that are recognized by the V primers (Vp) and the J primers (Jp) come into proximity after V(D)J rearrangement and allow , lanes 1-5) . In B, bottom, a control PCR reaction shows a 1,058-bp fragment amplified from exon 8 of CD3f (B, bottom, lanes I-7). Omission of template DNA in the reaction mixture gave no PCR products (B, lane 8). In C, the relative amounts of V(D)J-rearranged genomic DNA is compared between FT15.5 total (/eft), DN Fc'yRII/III +CD2-(middle), and DN Fc~RII/III-CD2 § (right) thymocyte populations. Fivefold titrations of genomic DNA from 1:1 (corresponding to ,'~100 ng) to 1:625 ('~I60 pg) were analyzed for V(D)J rearrangements (C, top) and in parallel for CD3g" exon 8 as a control (C, bottom). P C R amplification. Depending on the J~2 element to which either V~/6 or V~/8 genes are rearranged, five P C R products are amplified varying in size from ",~850 bp (VB6D32J32.1 or V38D32J32.1) to "2150 bp (V36DB2J32.5 or VB8D32-J~2.5) (see Fig. 5 A) . To verify the authenticity of the amplified sequences, P C R products were probed by southern hybridization using an oligonucleotide recognizing the 5' region of the J32.5 element independent from the J primer used for amplification.
To test the tissue specificity of this analysis for T C R chain rearrangement, genomic D N A was prepared from adult liver, lymph node (LN), fetal liver from day 16.5 in gestation (FL day 16.5), FT day 16.5, and FT day 15.5. As shown in Fig. 5 B, V(D)J rearrangement within the/3 gene locus is clearly detectable in LN, FT 16.5 day, and, to a lesser extent, in FT day 15.5. As expected, no rearrangement is detected in D N A derived from adult liver or FL day 16.5. To demonstrate the presence of intact D N A templates in all samples, a control P C R reaction was performed that amplified a sequence of 1,058 bp within exon 8 of CD3~" (Fig. 5 B, bottom) , lanes I-7) from all templates. Both reactions were template dependent since omission of template DNA in the reaction mixture gave no PCR product (Fig. 5 B, lane 8) .
In parallel, V(D)J rearrangement of the B gene locus was compared between the two subpopulations of day 15.5 DN thymocytes that showed kinetic differences in their in vivo development (Fig. 4 B) . To this end, FcyRII/III+CD2 -and FcyRII/III-CD2 + subpopulations derived from day 15.5 in gestation were separated according to their phenotype by cell sorting (see Fig. 4 A) , and DNA templates derived from sorted subpopulations were tested for B gene V(D)J rearrangement. Rearrangement was predominantly detected in the FcyRII/ III-CD2 + subpopulation as opposed to Fc3'RII/III+CD2 -thymocytes (Fig. 5 B, top, lanes 6 and 7) .
Since this first analysis suggested differences in TCR/3 gene V(D)J rearrangements between DN Fc3,KII/III+CD2 -and DN Fc"/RII/III-CD2 + thymocytes, subsequent experiments were performed to quantify such differences. Genomic DNA templates from FT day 15.5 total, DN Fc~/RII/III+CD2 -, and DN Fc3,RII/III-CD2 + subpopulations were titrated from 1:1 (corresponding to -100 ng genomic DNA) to 1:625 ("-,160 pg genomic DNA) and used as templates to detect V(D)J~ chain rearrangements (Fig. 5 C, top). Parallel analysis of CD3~" exon 8 was used as a control (Fig. 5 C, bottom) . Five bands corresponding to V/36 + 8DB2J~2.1-2.5 are clearly detectable using the highest DNA template concentrations in FT day 15.5 total (Fig. 5 C, top left) and in DN Fc3,KII/III-CD2 + (Fig. 5 C, top right) . The amount of amplified DNA derived from the highest template concentration (1:1) from DN Fc3,RII/III+CD2 -thymocytes is comparable to the amount of DNA obtained with the 1:25 template dilution from DN Fc'yRII/III-CD2 + thymocytes. Two conditions to allow quantification of template DNA by PCR are fulfilled: (a) DNA template is not present at saturating amounts since the PCR reaction is sensitive to template titration; and (b) the control amplification (Fig. 5 C, bottom) shows comparable dose-response curves for all three tested populations. If anything, there is more template DNA in the FcyRII/III+CD2 -and FT day 15.5 total samples relative to the Fc3rRII/III-CD2 + sample based on the control CD3~" signal. Thus, DN Fc3,RII/III-CD2 + thymocytes contain >--25-fold more V(D)J (8 chain)-rearranged genomic DNA when compared with DN Fc3,RII/ III + CD2-thymocytes. Since the sorted populations were "~98% pure, it cannot be excluded that the detectable V(D)J gene rearrangement among DN Fc'yRII/III +CD2-thymocytes is due to contaminating DN Fc'yRII/III-CD2 + cells. Collectively, these data demonstrate that TCR B gene V(D)J rearrangement at day 15.5 in gestation is predominantly if not exclusively present in the DN Fc'yKII/III-CD2 + subpopulation, while the majority of the DN Fc~/RII/ III+CD2 -thymocytes represent either cells at a pre-V(D)J (/$ chain) stage in T cell ontogeny (Fig. 4, B and C) or separate lineages uncommitted to the TCR-c~/B lineage. The latter could include cells of the TCR-7/6 lineage or non-T cells. However, as shown in Fig. 3 , the 3'//~ population represents a minor fraction of fetal DN FcyRII/III + thymocytes. Furthermore, the high level of Thy-1 expression is consistent with a T lineage designation of the majority of Fc3,RII/ III + CD2-thymocytes. (19) for expression of FcyRII/III and CD2. B and T cells from RAG-2-/-mice are unable to rearrange their Ig and TCR genes, respectively, and RAG-2 -/-thymocytes have previously been shown to be developmentally arrested at the DN stage (19) . Normal adult mouse thymocytes (see below) as well as thymocytes derived from adult RAG-2 +/-mice contain <3% of Fc3,RII/IIIexpressing cells (Fig. 6 A-C, top) . In contrast, ~15% of thymocytes derived from RAG-2-/-mice are Fc3~RII/III + (Fig. 6, A-C, bottom) , showing that Fc3,RII/III + expression is not blocked by the RAG-2 defect. To further analyze this thymocyte subset phenotypically, thymocytes derived from RAG-2 +/-mice and RAG-2 -/-mice were analyzed by two-color immunofluorescence for expression of Fc3,RII/III vs. Thy-1, HSA, and CD2, respectively. To exclude the possibility that the hypocellular thymus from RAG-2-/-mice ('~100-fold reduction in the total cell number of thymocytes [19] ) contains relatively enriched populations of contaminating Fc'yRII/III + macrophages or granulocytes, thymocytes from RAG-2 +/-mice and tLAG-2 -/-mice were analyzed for coexpression of Thy-1 and HSA vs. Fc3'RII/III. As shown in Fig. 6, A and B, while a small fraction of the Fc3,RII/III + thymocytes was Thy-1-and HSA-, the majority coexpressed high levels of Thy-1 (Fig. 6 A, bottom) and HSA (Fig. 6 B, bottom) , which are phenotypic characteristics of immature thymocytes.
The Majority of Adult Thymocytes from Rearrangement-deficient RAG-2 -/-Mice
In view of the fact that the in vivo kinetic experiments using fetal thymocytes had indicated a maturation sequence of Fc'yRII/III+CD2 ---* Fc'yRII/III+CD2 + --* Fc'yRII/ III-CD2 +, we next analyzed thymocytes from adult RAG-2 +/-mice and RAG-2 -/-mice for expression of Fc3,RII/III and CD2 (Fig. 6 C) . Interestingly, this phenotypic comparison revealed that the development of DN thymocytes in RAG-2 -/-mice is blocked before the Fc3,RII/ III-CD2 + stage. While RAG-2 +/-mice as well as normal adult mice contain ,,o95% Fc3,RII/III-CD2 § thymocytes and <3% Fc~,RII/III+CD2 + cells (Fig. 6 C, top) , <3% of RAG-2 -/-thymocytes are Fc'yRII/III-CD2 + (Fig. 6 C,   bottom) . In contrast to the virtually complete absence of CD4 and CD8 expression in RAG-2 -/-thymocytes, however, CD2 expression is not completely abrogated in RAG-2-/-mice. Nevertheless, CD2 expression is restricted to <10% of thymocytes and is largely confined to the Fc3,RII/III+CD2 + subset. However, the majority (,,o70%) of FcyRII/III + thymocytes is CD2-. It thus appears that two stages of early thymocyte development (DN Fc3,RII/ III+CD2 -and DN Fc3,RII/III+CD2 +) that were detect- able in fetal mice are present and, on a percentage basis, overrepresented in RAG-2-/-mice due to the developmental arrest. Thus, the developmental progression of thymocytes entering the TCR-oEB pathway as observed in fetal mice (Fig. 2 C) appears to be blocked immediately before entry into the Fc"/RII/III-CD2 + stage in thymocytes due to the RAG-2 mutation, which prevents TCR gene rearrangement. However, ,080% of the adult RAG-2-/-thymocytes express neither CD2 nor FcyRII/[II and thus cannot be assigned to the developmental sequence described herein. Note that in view of the hypocellularity of the RAG-2-/-thymus (19) , the absolute number of FcTRII/III + thymocytes is not increased, suggesting that the rearrangement defect perturbs early development, which directly or indirectly affects the generation of FcTRII/III + and CD2 + thymocytes. In contrast to mature human B lymphocytes, murine B cells express CD2 (47, 48) . The finding that the expression of CD2 in thymocytes is largely abrogated in RAG-2-/-mice (Fig.  6 C) prompted us to analyze the potential influence of the developmental blockade at the pro-B cell stage (Ig genes in germline, B22ff ~ on the expression of CD2 in RAG-2-/-mice. Splenocytes derived from RAG-2 +/- (Fig. 6 D, top) and RAG-2-/- (Fig. 6 D, bottom) mice were analyzed for expression of CD2 vs. B220. While the majority of B lineage cells in the RAG-2 § spleen express high levels of B220, B lineage cells from RAG-2-/-mice express low levels of B220 (Fig. 6 D, bottom) , as described (19, 49) . All B220hig h splenocytes from RAG-2 +/-spleen coexpress CD2. In contrast, RAG-2-/-splenocytes contain both B220+CD2 + and B220+CD2 -cells, suggesting that CD2 can be expressed in B cell progenitors that carry their Ig genes still in germline configuration. Thus, in contrast to T cell progenitors, the RAG-2 mutation does not appear to block CD2 expression in the B lineage.
Normal Adult CD3-CD4-CDS-Thymocytes Contain FcTRII/III+CD2 -, Fc'yRII/III+CD2 + and FcTRII/III-CD2 + Subpopulations. To test whether Fc"/RII/III+CD2 -, FcyRII/III + CD2 +, or FcyRII/III-CD2 + thymocyte subpopulations are also present in postnatal life among immature thymocytes, CD3-CD4-CDS-thymocytes were purlfled from the adult thymus. To this end, adult thymocytes were stained with a combination of anti-CD3, anti-CD4, and anti-CD8 mAbs, and antibody-coated cells were subsequently removed by two rounds of magnetic bead depletion followed by cell sorter separation. This purification method yielded "098% pure CD3-CD4-CD8-thymocytes. CD3-CD4-CD8-thymocytes were then examined for expression of FcyRII/III and CD2 (Fig. 7 D) . Negative controls as well as single-color controls are shown in Fig. 7 , A-C. To test specific binding of mAb 2.4G2 to the thymocytes, the binding of 2.4G2-FITC was blocked by preincubation with excess of unlabeled 2.4G2 (Fig. 7 A) . "015% of CD3-CD4-CDS-thymocytes express FcTRII/III (Fig. 7 B) , and ,020% stain weakly for CD2 (Fig. 7 C) . Two-color FcTRII/III and CD2 fluorescence analysis reveals "012% Fc~RII/III + CD2-, "04% FcTRII/III+CD2 +, and "016% FcTRII/III-CD2 + thymocytes (Fig. 7 D) . These subpopulations of Fc~RII/ III+CD2 -and FcTRII/III-CD2 + among normal adult CD3-CD4-CDS-thymocytes resemble the phenotypic subpopulations identified in fetal development (Fig. 2 C) , as well as after the developmental arrest in RAG-2-deficient mice (Fig. 7 C) . In contrast to RAG-2-/-thymocytes, however, normal adult CD3-CD4-CDS-thymocytes do contain a substantial percentage of FcTRII/III-CD2 + cells (>15%). 
Discussion
In previous work, we have identified the expression of Fc3' receptors for IgG (Fc~RII/III, CD16) on the majority of early fetal (DN) thymocytes (13) . In addition to the early appearance of this cell population in thymic ontogeny, several observations suggested that the Fc'yRII/III + thymocyte population would represent an early stage in T cell development. First, this cell population contains relatively uncommitted cells, which could give rise to T cells and NK cells in a microenvironment-dependent way. Second, Fc3,RII/III expression was shown to be downregulated early in thymocyte development (between the DN and DP stages). Although Fc~RII/III expression precedes the cell surface expression of TCR-c~/B by several days in gestation, Fc3,RII/III downregulation appears to correlate with the entry of developing thymocytes into the TCR Tiol/B lineage pathway. Support for this view comes from the finding that loss of Fc3~RII/III expression is only induced in the thymus. In contrast, early fetal thymocytes grown in in vitro suspension cultures in the presence of IL-2, or "parked" in the spleen in vivo after intravenous transfer of donor-type fetal thymocytes, maintained expression of Fc3~RII/III (13).
Here we provide further evidence that FcyRII/III expression is detectable at very early stages of intrathymic development and, more precisely, characterized its appearance and disappearance. We observe that on day 15.5 of gestation, the majority of the ontogenetically primitive population of CD4 l~ SP thymocytes is Fc3~RII/III + (Fig. 1 D) . Moreover, fractions of FcyRII/III + thymocytes include Thy-1 l~ IL-2R (p55)-, CD2-, and HSA l~ cells (Fig. 2, A-D) . Very early intrathymic progenitor populations have been phenotypically characterized as Thy-1 l~ Scal +, HSA l~ Pgp-1 +, CD3-, CD4 -/~ow, CD8-, IL-2R (p55)- (38, 42, 43, 45, 50) . Consequently, the phenotype of at least a fraction of the Fc3~RII/III-expressing thymocytes is consistent with the expression pattern of very early thymocytes. However, Fc3,RII/III-expressing thymocytes also include more mature DN stages of thymocyte development.
In preliminary experiments designed to test whether prethymic hematopoietic cells derived from fetal liver contain FcyRII/III + T cell progenitors, we isolated Fc3,RII/ III + fetal liver cells from day 15.5 in gestation (representing 5-15 % of the total population), and analyzed their developmental potential upon intrathymic injection in vivo. FcyRII/ III § fetal liver cells contained T cell progenitor activity, but did not appear to provide a means to enrich for such activity since Fc3'RII/III-fetal liver cells also expressed T cell progenitor activity (not shown). Collectively, these experiments indicate that developing thymocytes express Fc3'RII/III very early in T cell ontogeny and that fetal liver-derived T cell progenitors potentially carry FcyRII/III as thymic immigrants.
The progenitor activity of DN Fc3,RII/III § cells for the generation of TCR-ol/B + thymocytes inside the thymus has been demonstrated (13) . In the present work, the kinetics of this in vivo differentiation is described in detail. It is also likely that a fraction of DN Fc-yRII/III-thymocytes enters the TCR-3~/8 lineage. While we have previously identified Fc3d~II/III + TCR-3~/8 + thymocytes after in vitro culture of fetal thymocytes in the presence of IL-2 (13), the current study demonstrates the presence of such cells in situ. Although the precursor-product relationship of DN Fc'yRII/III + thymocytes and mature TCR-3,/8 + T cells remains to be directly shown, it is conceivable that the Fc'),RII/III + TCR-"y/8 + thymocytes identified herein represent an intrathymic stage of TCR-y/~ epidermal dendritic T cells. It is noteworthy that these epidermal cells express Fc~RII/III (51) .
Developing thymocytes entering the TCR-ol/3 pathway cease to express FcyRII/III at the DN stage and before the entry into the CD3-CD8 l~ stage. Later phases of thymocytes (DP and mature SP) are Fc3~RII/III- (Fig. 1 B) . This downregulation of Fc3,RII/III expression at an immature thymocyte stage is in contrast to FcyRII expression during B cell ontogeny. Recently, phenotypic analysis of developing B cells has demonstrated the expression of Fc3~RII as early as at the pre-B cell stage (52) . Unlike mature T cells, however, B lineage cells continue to express Fc~ receptors as mature B cells (53, 54) .
Interestingly, the downregulation of FcyRII/III expression on DN thymocytes entering the TCR-od3 pathway contrasts with the upregulation of CD2just before the exit from the DN stage and allows the separation of DN thymocytes into three novel phenotypic subsets. The sequential appearance in thymic ontogeny of first Fc3,RII/III+CD2 -and latter Fc~RII/III-CD2 + thymocytes (Fig. 2 C) was assessed by flow cytometry. Moreover, the developmental delay of CD4 and CD8 coexpression as well as the generation of mature SP thymocytes (Fig. 4 B) by ~48 h after intrathymic injection of FcyRII/III+CD2 -when compared with Fc~RII/ III-CD2 § characterize Fc3,RII/III+CD2 -and Fc~RII/ III-CD2 + DN subsets as distinct early and late stages, respectively, of the same pathway leading into the Tio~/3 lineage.
Our kinetic measurements of the development of fetal thymocytes entering the TCR-oc/B pathway after adoptive transfer into normal nonirradiated recipients are consistent with previously reported in vivo kinetics of developing thymocytes. The transition time from the DN to the DP stage, ranging from 1.5 d (FcyRII/III+CD2 -) to 3.5 d (Fc?RII/ III-CD2 +) (Fig. 4 B) , resembles the in vivo kinetics reported by Petriet al. (34) , who compared maturational stages of adult DN Pgp-1-IL-2Rot + and DN Pgp-1-Ib2Ro~-thymocytes in normal recipient mice. Progeny of Fc3,RII/ III + CD2-and Fc3'RII/III-CD2 + DN thymocytes remain at the DP stage for 48-72 h (Fig. 4 B) before they are selected into the SP thymocyte compartment (Fig. 4 C) . Huesmann et al. (55) estimated the life span of DP thymocytes in TCR transgenic mice using bromodeoxyuridine (BrdU) labeling in vivo to be 3.5 d. Thus, both in vivo DNA labeling and adoptive transfer of precursor populations into normal, nonirradiated recipients yield comparable kinetics and are most likely to reflect the steady-state physiology of intrathymic T cell development.
Undifferentiated "prothymocytes" entering the thymus carry their TCR genes in germline configuration (38, 43 (Fig. 3) . Likewise, the pool of nonoT lineage cells contained within the DN FcyRII/III+CD2-subpopulation appears small given the high Thy-1 and HSA expression on this population (Fig.  2) . The difference in rearrangement status directly supports our suggestion that DN Fcq, RII/III+CD2 -and DN Fc3,RII/III-CD2 + cells are early and late DN populations, respectively. Furthermore, V(D)J/5 chain rearrangement is temporally correlated with the termination of FcyRII/III expression. The molecular understanding of antigen receptor gene rearrangement has been advanced by the identification of two recombination activation genes, termed RAG-1 and tLAG-2 (reviewed in references 56 and 57). RAG-1 and RAG-2 mRNAs are expressed in immature B and T lymphocyte progenitor populations that actively rearrange their antigen receptor genes. Together, these genes confer recombination activity upon transfection into nonrearranging cells (18) . Until recently, little was known about the influence of productive TCR gene rearrangements on the regulation of intrathymic developmental progression. Gene-targeting experiments in which RAG-1 or RAG-2 loci were mutated have now demonstrated the essential nature of both genes for the somatic recombination process (19, 49) . Mice expressing the RAG-1 -/-or RAG-2 -/-genotype lack both mature B and T lymphocytes and thus, in phenotype, resemble animals with a naturally occurring SCID syndrome (reviewed in reference 58). Specifically, thymocytes from RAG-2-/-mice are developmentally arrested at the DN stage before the assembly and surface expression of the TCR. In addition, the RAG-2 mutation leads to a reduction to '~1% of the normal number of thymocytes (19) . Similar effects have been noted in SCID mice since SCID thymocytes are also arrested at the DN stage (58) .
While both DN Fcq'RII/III+CD2 -and DN FcyRII/ III+CD2 § populations are present and their relative percentages enriched in RAG-2 -/-when compared with RAG-2 +/-thymocytes, strikingly, the DN Fc~RII/III-CD2 + population is reduced from >95% (RAG-2 +/-) to <3% (RAG-2 -/-) (Fig. 6 C) . Thus, persistence of TCR genes in germline configuration in the early developing thymocytes has a dramatic inhibitory effect, directly or indirectly, on CD2 expression at the late DN stage. Expression of CD2 occurs after V(D)J/5 chain rearrangement in thymic development and, much like CD4 and CD8 expression (19, 49) , appears to be, in large part, linked to V(D)J/5 chain rearrangement. In this context, it is interesting that transfection of a TCR/3 chain gene into a SCID-derived cell line led to upregulation of CD2 surface expression in addition to surface expression of a Ti/5-/5 homodimer (59). The mechanism by which the rearranged TCR/5 chain mediates transcriptional and/or translational control of these genes and their products remains to be determined. These results suggest that the expression of the TCR ~ chain provides a critical signal for development beyond the DN and into the DP stage. Consistent with this hypothesis, SCID mice expressing a transgenic TCR/5 chain contain normal percentages of DP thymocytes (59) . Moreover, in RAG-l-/-and RAG-2-/-mice, which carry fully rearranged transgenic TCR/3 chains, thymocytes are released from their differentiation block at the DN stage and progress into the DP stage (60, 61) .
The role of Fc3'RII/III on early CD4 ]~ thymocytes and DN thymocytes during thymic differentiation is unknown. However, signaling function through the associated FceRI'y (62) or CD3~" (63-65) subunits may be important in the developmental process, mRNAs encoding FceRI3' and CD3~" proteins are present in the developing thymus as early as day 14 of gestation (13; data not shown). While IgG is the ligand of FcyRII/III on mature hematopoietic elements and NK cells, it is possible that an alternative ligand interacts with the ectodomain of Fcq, RII/III expressed on early thymic precursors. It is now important to define the precise function of this molecule during thymocyte development.
It is apparent that there is no requirement for CD2 expression before induction of TCR gene rearrangement. This notion is consistent with the previous demonstration of the presence of CD2-CD3 + DN thymocytes in the mouse (14) . Rather, TCR/5 gene V(D)J rearrangement in DN thymocytes is necessary for normal CD2 surface expression. More specifically, fixation of the TCR genes in germline configuration largely prevents the differentiation of DN thymocytes into the Fc'yRII/III-CD2 + stage. It is undoubtedly noteworthy that CD2 expression precedes and is maintained through the DP thymocyte stage because it is at this latter stage that positive and negative selection events are ongoing. The adhesion function of CD2 may well facilitate cell-cell contact important in the thymic "education" process. In this regard, repertoire selection of the TCRs in humans and mice could be influenced by the presence of CD2. Clearly, further studies are required to address this issue, particularly because murine and human CD2 bind related but distinct ligands, CD48 and CD58 (LFA-3), respectively, with different tissue distributions (66) . Nonetheless, the functional dissection provided by the elucidation of the DN subpopulations described through our analysis should allow us to further define the orderly steps in thymic development in the mouse.
